Status:
COMPLETED
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Pediatric Neoplasm
Quality of Life
Eligibility:
All Genders
2-25 years
Phase:
NA
Brief Summary
Over 50% of children dying from cancer still suffer from symptoms that could be effectively alleviated. The purpose of the Pediatric Quality of Life and Evaluation of Symptoms Technology (PediQUEST) S...
Detailed Description
Introduction: Cancer is the leading cause of nonaccidental death in childhood.(Arias et al. 2003) In spite of significant scientific progress, one quarter of children with cancer still do not survive(...
Eligibility Criteria
Inclusion
- Children \>=2-years old with at least a 2-week history of progressive, recurrent, or non-responsive cancer of any type or decision not to pursue cancer directed therapy.
- Child's parent must have spoken and written command of English or Spanish.
- Child's parent must have the ability to understand and complete self-administered surveys.
Exclusion
- Patients who have an isolated relapsed solid tumor treated with surgery or radiation alone.
- Patients with hematological malignancies who have achieved remission after the first induction attempt, whose treatment plan includes their first Stem Cell Transplant (SCT), and have an identified donor (must meet all 3 criteria to be excluded).
- Patients who are not regular patients at one of the two participating institutions.
- Foster parents who do not have legal guardianship.
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01838564
Start Date
November 1 2004
End Date
June 1 2010
Last Update
April 29 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
3
Children's Hospital of Philapdelphia
Philadelphia, Pennsylvania, United States, 19104
4
Seattle Children's Hospital
Seattle, Washington, United States, 98105